Left Atrial Appendage (LAA) Closure Device Market Size (USD 8.2 billion by 2031): Evolving Trends, Innovations, and Growth Factors

The left atrial appendage (LAA) is a small ear-shaped sac which is present in the wall of the top left chamber of the heart. This sac controls the electrical impulses during atrial fibrillation. The LAA closure devices are the interventional devices that is used to prevent stroke and emboli caused due to atrial fibrillation. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.

Allied Market Research published a report, titled, “Left Atrial Appendage (LAA) Closure Device Market by Product (Endocardial LAA Devices, Epicardial LAA Devices), by End Use (Hospitals, Ambulatory Surgery Centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031.” According to the report, the global left atrial appendage closure device industry generated USD 1.3 billion in 2021 and is estimated to reach USD 8.2 billion by 2031, witnessing a CAGR of 21.0% from 2022 to 2031.

Get Sample PDF Report with Graphs and Figures Here: https://www.alliedmarketresearch.com/request-sample/3699

𝐖𝐡𝐚𝐭 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐟𝐚𝐜𝐭𝐨𝐫𝐬 𝐝𝐫𝐢𝐯𝐢𝐧𝐠 𝐭𝐡𝐞 𝐋𝐞𝐟𝐭 𝐀𝐭𝐫𝐢𝐚𝐥 𝐀𝐩𝐩𝐞𝐧𝐝𝐚𝐠𝐞 (𝐋𝐀𝐀) 𝐂𝐥𝐨𝐬𝐮𝐫𝐞 𝐃𝐞𝐯𝐢𝐜𝐞 𝐌𝐚𝐫𝐤𝐞𝐭?

Rise in number product approvals for atrial intervention, surge in atrial fibrillation, heart stroke cases, and hypertension-related diseases, and unhealthy lifestyle choices such as smoking drive the growth of the global left atrial appendage closure device market. In addition, rise in initiatives to raise awareness in untapped regions supplement the market growth. However, high cost of devices and availability of substitutes in the market restrain the growth. On the other hand, increase in adoption of cutting-edge technologies and improvement in implant effectiveness and procedural safety present opportunities in the market.

𝐋𝐞𝐟𝐭 𝐀𝐭𝐫𝐢𝐚𝐥 𝐀𝐩𝐩𝐞𝐧𝐝𝐚𝐠𝐞 (𝐋𝐀𝐀) 𝐂𝐥𝐨𝐬𝐮𝐫𝐞 𝐃𝐞𝐯𝐢𝐜𝐞 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬: –

• SentreHEART, Inc.
• Boston Scientific Corporation
• AtriCure, Inc.
• Abbott Laboratories
• Occlutech
• Lifetech Scientific Corporation
• Cardia, Inc.
• Aegis Medical Group
• Biosense Webster, Inc.
• Johnson & Johnson Services, Inc

 𝐆𝐥𝐨𝐛𝐚𝐥 𝐋𝐞𝐟𝐭 𝐀𝐭𝐫𝐢𝐚𝐥 𝐀𝐩𝐩𝐞𝐧𝐝𝐚𝐠𝐞 𝐂𝐥𝐨𝐬𝐮𝐫𝐞 𝐃𝐞𝐯𝐢𝐜𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: –

Based on product, the endocardial LAA devices segment contributed to the highest market share in 2021, accounting for around 90% of the global left atrial appendage closure device market, and is projected to maintain its lead position during the forecast period. Moreover, this segment is estimated to manifest the largest CAGR of 21.2% from 2022 to 2031. This is due to lower complications in patients, shorter hospital stays, and safer and more effective in managing stroke and reducing bleeding than other products. The report also analyzes the epicardial LAA devices segment.

Based on end use, the hospitals segment accounted for the largest market share in 2021, holding around three-fourths of the global left atrial appendage closure device market, and is estimated to continue its highest contribution throughout the forecast period. In addition, this segment is projected to register the fastest CAGR of 21.4% from 2022 to 2031. This is due to preference for left atrial appendage (LAA) procedures and increase in hospital acceptance of LAA closure devices with availability of advanced medical technologies and skilled professionals. The research also analyzes the segments including ambulatory surgery centers and others.

Based on region, North America held the largest market share in 2021, accounting for nearly half of the global left atrial appendage closure device market, and is projected to maintain its dominance in terms of revenue during the forecast period.

This is due to widespread acceptance of advanced left atrial appendage closure devices, rise in incidence of atrial fibrillation, and well-developed healthcare infrastructure. However, Asia-Pacific is projected to grow at the largest CAGR of 22.2% from 2022 to 2031, owing to high preference and acceptance of advanced technologies in closure devices in medical facilities in the region.

Purchase the Report: https://www.alliedmarketresearch.com/purchase-enquiry/3699

Our Market Research Solution Provides You Answer to Below Mentioned Question:

• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
• How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
• Which region has more opportunities?

By Region Outlook 

• North America
  (U.S., Canada, Mexico)
• Europe
  (Germany, France, UK, Italy, Spain, Rest of Europe)
• Asia-Pacific
  (Japan, China, India, Rest of Asia-Pacific)
• LAMEA
  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Contact Details:
David Correa
USA/Canada (Toll-Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.